What happens to your side effects when you stop Wegovy

The myth worth correcting first: stopping Wegovy doesn't end side effects overnight for everyone

A reasonable assumption is that once you stop Wegovy, the side effects simply switch off. For many people the GI symptoms (nausea, burping, constipation or loose stools) do fade within days, and that matches what the NHS medicines page for semaglutide describes: these effects are most pronounced when starting or moving up a dose, and they diminish as your body adjusts. After your last injection, semaglutide gradually clears over a few weeks (its half-life means meaningful levels persist for roughly four to five weeks), so some people find side effects taper rather than stop sharply.

What the myth misses is the other direction. Stopping isn't just an absence of the medicine's effects, it's also the loss of the appetite-suppressing and gastric-slowing action that Wegovy produces. Hunger can return with surprising intensity. Some people describe food feeling more compelling than it did before they started. That isn't a personal failing; it reflects the biology the medicine was modulating. Understanding this before you stop (rather than after) tends to make the transition far less unsettling. You can read more about what the full side-effect profile looks like during treatment for additional context.

If you're currently experiencing side effects and wondering when they'll ease on their own, understanding when you feel side effects of Wegovy is worth reading alongside the pattern during active treatment: most GI effects tend to peak shortly after a dose increase and settle within one to two weeks at each new level.

What the evidence says about side effects in the weeks after your last dose

There is no single clinical trial dedicated to the question of what happens physiologically to side effects specifically after stopping Wegovy, but the STEP programme data and the licensed SmPC give useful signal. The STEP 1 trial, published in the New England Journal of Medicine, followed participants who stopped semaglutide at 68 weeks and found that weight loss reversed substantially within a year as appetite and body weight trended back toward baseline. That rebound is the most clinically significant thing that tends to happen when Wegovy stops.

On the side-effect side, the picture is broadly reassuring: the GI symptoms that are most common during treatment are tied to the medicine's presence and activity. As semaglutide levels fall, gastric emptying returns toward its previous pace, appetite signals reactivate, and nausea becomes much less likely. Most people find they feel physically more like themselves within a fortnight of stopping. The practical implication is that if you were tolerating treatment reasonably well but want to pause for a specific reason (surgery, pregnancy planning, a supply gap) the GI burden of restarting later is likely to resemble starting fresh, with symptoms possible at lower doses again. Managing semaglutide side effects during active treatment is a different challenge worth planning for if you restart.

When stopping Wegovy needs more than just waiting it out

It's worth being honest: deciding to stop a treatment you've found difficult is emotionally loaded. You might feel relief, or guilt, or simply exhausted from months of nausea. All of that is understandable. The clinical question is whether symptoms appearing around the time you stop warrant more than watchful waiting.

Seek urgent medical attention if you develop severe, persistent stomach pain, especially pain that reaches through to your back, with or without vomiting. This can be a sign of pancreatitis, which the MHRA flagged in a January 2026 Drug Safety Update as a known but infrequent risk with GLP-1 medicines. The timing relative to stopping is less important than the symptom itself: if the pain is severe and doesn't ease, get assessed that day. Signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing, rapid heartbeat) also need emergency care. Gallbladder symptoms (sharp pain in the upper right abdomen, especially after eating) should prompt a GP call rather than self-management.

For symptoms that are uncomfortable but not urgent, the MHRA Yellow Card scheme lets you report suspected side effects directly, including those that appear after stopping. Reports help build the evidence base for everyone who takes these medicines after you. Our FAQs cover a number of questions about managing side effects during and after treatment.

What a stopping plan actually looks like with clinical support

Stopping Wegovy without a conversation with your prescriber isn't dangerous in the way that stopping some medicines abruptly is. There's no acute withdrawal syndrome specific to semaglutide. But going without a plan does mean you're likely to face returning appetite without strategies in place, and potentially without the lifestyle support that makes the difference to long-term outcomes.

A sensible stopping plan usually covers a few things: whether to taper or stop at the current dose, what to expect over the first four to six weeks, whether lifestyle changes or an alternative treatment are appropriate, and how to monitor weight so that meaningful regain triggers a review rather than a slow drift. Practical strategies for managing side effects before you reach the decision to stop are worth exploring first if you're still in active treatment. If you've already stopped and want to understand your options going forward, our overview of licensed weight-loss treatments sets out what's available through a private prescriber. For anyone considering starting or restarting treatment, how Wegovy is dispensed through a regulated UK pharmacy is explained step by step. Our prescribers discuss suitability, side-effect history and individual circumstances as part of every consultation, you can start a free consultation to have that conversation.